NCT00042224View on ClinicalTrials.gov

Electroconvulsive Therapy in Clozapine Refractory Schizophrenia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

December 31, 2000

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Schizophrenia
Interventions
PROCEDURE

Electroconvulsive Therapy (ECT)

ECT will be used to augment clozapine in schizophrenic patients who continue to have psychotic symptoms despite optimal treatment with clozapine.

DRUG

Clozapine

Patients with psychotic symptoms will receive clozapine

Trial Locations (1)

11004

Zucker Hillside Hospital, Glen Oaks

Sponsors

Lead Sponsor

Northwell Health
All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Northwell Health

OTHER